Bone Health

Vertebral fracture definition from population-based data: preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos)

Jackson SA et al., 2000

Augmented trochanteric bone mineral density after modified physical education classes: a randomized school-based exercise intervention study in prepubescent and early pubescent children

McKay HA et al., 2000

Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos)

Tenenhouse A et al., 2000

Running and ovulation positively change cancellous bone in premenopausal women

Petit MA et al., 1999

Oral-contraceptive use and risk of hip fracture: a case-control study

Michaëlsson K et al., 1999

Research Notes: The Canadian Multicentre Osteoporosis Study (CaMos): Background, Rationale, Methods

Kreiger N et al., 1999

Spinal bone mineral density in premenopausal vegetarian and nonvegetarian women: cross-sectional and prospective comparisons

Barr SI et al., 1998

Oral contraception and other factors in relation to hospital referral for fracture. Findings in a large cohort study

Vessey M et al., 1998

Long-term effects of percutaneous estradiol on bone loss and bone metabolism in postmenopausal hysterectomized women

Devogelaer JP et al., 1998

Premenopausal ovariectomy-related bone loss: a randomized, double-blind, one-year trial of conjugated estrogen or medroxyprogesterone acetate

Prior JC et al., 1997

Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone, or placebo over 12 months

Hergenroeder AC et al., 1997

EXERCISE-ASSOCIATED CANCELLOUS BONE CHANGE: POSITIVE EFFECT OF OVULATION 1116

Petit MA et al., 1997

Menstrual and reproductive factors and hip fractures in post menopausal women

Parazzini F et al., 1996

Effect of estriol on bone loss in postmenopausal Japanese women: a multicenter prospective open study

Minaguchi H et al., 1996

Risk factors, falls, and fracture of the distal forearm in Manchester, UK

O'Neill TW et al., 1996

Ovulatory premenopausal women lose cancellous spinal bone: a five year prospective study

Prior JC et al., 1996

Low and conventional dose transdermal oestradiol are equally effective at preventing bone loss in spine and femur at all post-menopausal ages

Evans SF et al., 1996

Osteoporosis risk factors, gynaecological history and fractures in perimenopausal women--the results of the baseline postal enquiry of the Kuopio Osteoporosis Risk Factor and Prevention Study

Tuppurainen M et al., 1993

Effect of transdermal 17 beta-estradiol and oral conjugated equine estrogens on biochemical parameters of bone resorption in natural menopause

Reginster JY et al., 1993

Oral contraceptive pill use and fractures in women: a prospective study

Cooper C et al., 1993

Low-dosage micronized 17 beta-estradiol prevents bone loss in postmenopausal women

Ettinger B et al., 1992

Spinal bone loss and ovulatory disturbances

Prior JC et al., 1990

Progesterone as a bone-trophic hormone

Prior JC, 1990

Bone mineral density in women with endometriosis before and during ovarian suppression with gonadotropin-releasing hormone agonists or danazol

Tummon IS et al., 1988

Dialysis encephalopathy and osteomalacic bone disease: a case-controlled study

Prior JC et al., 1982

Vitamin D intakes among women living with and without HIV in Canada

King EM et al., 2023

Testosterone supplementation and bone parameters: a systematic review and meta-analysis study

Corona G et al., 2022

Where's the break? Critique of radiographic vertebral fracture diagnostic methods

Prior JC et al., 2021

Pivotal role of boron supplementation on bone health: A narrative review

Rondanelli M et al., 2020

Testosterone treatment in male patients with Klinefelter syndrome: a systematic review and meta-analysis

Pizzocaro A et al., 2020

Effects of progesterone therapy on serum sclerostin levels in healthy menopausal women: a 3-month randomized, placebo-controlled clinical trial

Yang YB et al., 2020

Prevalence of Female Athlete Triad Risk Factors and Iron Supplementation Among High School Distance Runners: Results From a Triad Risk Screening Tool

Skorseth P et al., 2020

INSL3: A Marker of Leydig Cell Function and Testis-Bone-Skeletal Muscle Network

Facondo P et al., 2020

Systemic administration of low-dose naltrexone increases bone mass due to blockade of opioid growth factor receptor signaling in mice osteoblasts

Tanaka K et al., 2019

SUN-537 Progesterone Therapy and Serum Sclerostin Levels in Healthy Menopausal Women: A 3-month Randomized, Placebo Controlled Clinical Trial

Yang Y et al., 2019

Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study

Bliuc D et al., 2019

Progesterone for the prevention and treatment of osteoporosis in women

Prior JC, 2018

Dietary patterns in men and women are simultaneously determinants of altered glucose metabolism and bone metabolism

Langsetmo L et al., 2016

Calcium and vitamin D intake and mortality: results from the Canadian Multicentre Osteoporosis Study (CaMos)

Langsetmo L et al., 2013

The female athlete triad

Nazem TG et al., 2012

Osteoporosis-related fracture case definitions for population-based administrative data

Lix LM et al., 2012

Implications of vitamin D deficiency in pregnancy and lactation

Mulligan ML et al., 2010

Dietary patterns in Canadian men and women ages 25 and older: relationship to demographics, body mass index, and bone mineral density

Langsetmo L et al., 2010

The menstrual cycle: a biological marker of general health in adolescents

Popat VB et al., 2008

Dual-Energy X-Ray Absorptiometry Technical issues: the 2007 ISCD Official Positions

Simonelli C et al., 2008

Vitamin D deficiency in a healthy group of mothers and newborn infants

Lee JM et al., 2007

2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada

Brown JP et al., 2002

Management of the extremely preterm infant: is the replacement of estradiol and progesterone beneficial?

Trotter A et al., 2001

Dietary restraint, exercise, and bone density in young women: are they related?

McLean JA et al., 2001

Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss

Leonetti HB et al., 1999

Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group

Women's Health Initiative Study Group, 1998

Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 5. Physical activity as therapy for osteoporosis

Prior JC et al., 1996

Cyclic medroxyprogesterone treatment increases bone density: a controlled trial in active women with menstrual cycle disturbances

Prior JC et al., 1994

Effect of dietary boron on mineral, estrogen, and testosterone metabolism in postmenopausal women

Nielsen FH et al., 1987

Hemodialysis patients with a unique mineralizing defect unresponsive to 1,25-dihydroxycholecalciferol. Dialysis osteomalacic syndrome

Cameron EC et al., 1980

Experience with 1,25-dihydroxycholecalciferol therapy in undergoing hemodialysis patients with progressive vitamin D2-treated osteodystrophy

Prior JC et al., 1979